Paul S. Herendeen
2018 - Valeant Pharmaceuticals International
Compensation breakdown
| Non-Equity Incentive Plan | $2,028,000 |
|---|---|
| Option Awards | $1,049,860 |
| Salary | $1,000,000 |
| Stock Awards | $2,310,572 |
| Other | $12,375 |
| Total | $6,400,807 |
Herendeen received $2.3M in stock awards, accounting for 36% of the total pay in 2018.
Herendeen also received $2M in non-equity incentive plan, $1M in option awards, $1M in salary and $12.4K in other compensation.
Rankings
In 2018, Paul S. Herendeen's compensation ranked 1,427th out of 14,244 executives tracked by ExecPay. In other words, Herendeen earned more than 90.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,427 out of 14,244 | 90th |
Division Manufacturing | 496 out of 5,765 | 91st |
Major group Chemicals And Allied Products | 154 out of 2,128 | 93rd |
Industry group Drugs | 121 out of 1,817 | 93rd |
Industry Pharmaceutical Preparations | 89 out of 1,391 | 94th |
Pay ratio
| Paul S. Herendeen's Pay | $6,400,807 |
|---|---|
| Median Employee's Pay | $37,872 |
| Pay Ratio | 169to 1 |
In 2018, the annual total compensation of Paul S. Herendeen was $6,400,807.
The annual total compensation of the median employee at Valeant Pharmaceuticals International was $37,872.
The ratio of Paul S. Herendeen's pay to the pay of median employee was therefore 169 to one.
Herendeen's colleagues
We found four more compensation records of executives who worked with Paul S. Herendeen at Valeant Pharmaceuticals International in 2018.
2018
Joseph Papa
Valeant Pharmaceuticals International
Chief Executive Officer
2018
Thomas Appio
Valeant Pharmaceuticals International
President & Co, Head, Bausch + Lomb/International
2018
Christina Ackermann
Valeant Pharmaceuticals International
General Counsel
2018
Joseph Gordon
Valeant Pharmaceuticals International